749 participants
First-line Esophageal Carcinoma Study With Pembrolizumab Plus Chemo vs. Chemo (MK-3475-590/KEYNOTE-590)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-10-15
- Start Date:
- 2017-07-25
- Completion:
- 2020-07-02
Conditions
- Esophageal Neoplasms
Interventions
- BIOLOGICAL
- DRUG